NCT05765110Recruiting
SPEECH as Biomarker for Emotion, Movement and cOgnition in Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 22 May 2026
Brief summary (registry, in English)
With this study, the investigators want to investigate whether computerized speech analysis can be used to reliably and objectively detect motor, emotional, and cognitive fluctuations in Parkinson's disease patients.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- First submitted
- 11 Jan 2023
- Start date
- 3 Jan 2023
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Diseases
- Parkinson disease
- NCT number
- NCT05765110
What you commit to
- Study type: Interventional
- Planned participants: 80
- From 3 Jan 2023 to the primary completion date, 31 Dec 2026
- 2 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Dysarthria caused in addition by a condition other than PD (e.g. stroke, myasthenia);
- Brain disease other than Parkinson's disease (e.g. atypical Parkinsonism, Alzheimer's disease, vascular dementia, multiple sclerosis, stroke, traumatic brain injury, epilepsy, etc.).
- Cognitive impairment (Montreal Cognitive Assessment (MoCa) \< 24/30 points);
- Diagnosis of Parkinson's disease;
- Cognitive impairment (Montreal Cognitive Assessment (MoCa) \< 24/30 points);
- Suffering from brain disease (e.g. atypical Parkinsonism, Alzheimer's disease, vascular dementia, multiple sclerosis, stroke, traumatic brain injury, epilepsy, etc.);
- Suffering from or diagnosed with psychiatric illnesses according to DSM-V criteria
Other
- Clinical diagnosis of aphasia;
- Depression with acute suicidal ideation
- Healthy Controls
- Clinical diagnosis of aphasia, dysarthria, and stuttering;
Who the study is looking for
- Written informed consent
- Idiopathic PD according to the Movement Disorders Society Criteria;
- Age of participants \> 30 and ≤ 75 years;
- Treatment with or without bilateral deep brain stimulation in the subthalamic nucleus;
- Fluent in German or French
- Written informed consent
- Adults from 50-70 years old;
- Fluent in German or French
Criteria the registry did not label
- Patients with Parkinson's Disease
Age in the registry: 30 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Inselspital, Berne Coordinator of this site? Confirm its status | Bern | Switzerland | Recruiting |
| Czech Technical University Prague Coordinator of this site? Confirm its status | Prague | Czechia | Active, not recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.